Vimarsana
Biggest News Aggregation in the World

Page 13 - Repligen Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repligen Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repligen Daily Today - Breaking & Trending Today

Federated Hermes Inc. Sells 55,746 Shares of Repligen Co. (NASDAQ:RGEN) - Vimarsana News

Federated Hermes Inc. Sells 55,746 Shares of Repligen Co. (NASDAQ:RGEN)

Federated Hermes Inc. reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 11.0% in the first quarter, according to its most recent filing with the SEC. The fund owned 450,661 shares of the biotechnology company’s stock after selling 55,746 shares during the period. Federated Hermes Inc. owned approximately 0.81% of Repligen […]

Source: wkrb13.com
Exscientia (NASDAQ:EXAI) and Repligen (NASDAQ:RGEN) Head-To-Head Survey - Vimarsana News

Exscientia (NASDAQ:EXAI) and Repligen (NASDAQ:RGEN) Head-To-Head Survey

Repligen (NASDAQ:RGEN – Get Free Report) and Exscientia (NASDAQ:EXAI – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk and valuation. Volatility & Risk Repligen has a beta of 1.01, indicating […]

Royal Bank of Canada Raises Repligen (NASDAQ:RGEN) Price Target to $195.00 - Vimarsana News

Royal Bank of Canada Raises Repligen (NASDAQ:RGEN) Price Target to $195.00

Repligen (NASDAQ:RGEN – Free Report) had its price objective lifted by Royal Bank of Canada from $157.00 to $195.00 in a research report sent to investors on Thursday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the biotechnology company’s stock. Several other research analysts have also recently issued reports on […]

Repligen (NASDAQ:RGEN) Issues Quarterly Earnings Results - Vimarsana News

Repligen (NASDAQ:RGEN) Issues Quarterly Earnings Results

Repligen (NASDAQ:RGEN – Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.49 by $0.04, Briefing.com reports. The firm had revenue of $159.20 million for the quarter, compared to the consensus estimate of $165.93 million. Repligen had a net margin […]

Source: wkrb13.com
Repligen (NASDAQ:RGEN) Shares Up 5.9% - Vimarsana News

Repligen (NASDAQ:RGEN) Shares Up 5.9%

Repligen Co. (NASDAQ:RGEN – Get Free Report) shares shot up 5.9% on Wednesday . The stock traded as high as $181.26 and last traded at $177.01. 436,487 shares traded hands during mid-day trading, a decline of 26% from the average session volume of 590,124 shares. The stock had previously closed at $167.12. Analysts Set New […]